Radionuclide theranostics: advances and clinical applications in lung cancer. [PDF]
Yang Y +11 more
europepmc +1 more source
Synthesis, Radiochemical Characterization, and Biodistribution of a <sup>188</sup>Re Analogue of [<sup>131</sup>I]mIBG in a Neuroblastoma Xenograft Model. [PDF]
Sakhare N +11 more
europepmc +1 more source
Therapeutic Applications of Fibroblast Activation Protein (FAP)-Binding Radiopharmaceuticals: Review of Opportunities and Challenges. [PDF]
Maes J +9 more
europepmc +1 more source
Beyond discovery: are we understanding PET tracers as fast as we invent them? a critical review. [PDF]
Ibrahim EA.
europepmc +1 more source
Radiotherapy meets anticancer metallodrugs. [PDF]
Zhang S +5 more
europepmc +1 more source
Using advanced cell models for targeted radionuclide therapy evaluation: increased efficacy in 3D versus 2D. [PDF]
Klomp MJ +4 more
europepmc +1 more source
177Lu-based radioligand therapy: A retrospective multicenter analysis to calculate the effective half-life and follow-up dose for the public. [PDF]
Schütze C +14 more
europepmc +1 more source
An intra-patient contemporaneous comparison of <sup>18</sup>F-piflufolastat and <sup>18</sup>F-flotufolastat urinary radioactivity and pelvic region detection rates in men with low PSA biochemical recurrence of prostate cancer after radical prostatectomy. [PDF]
Nordquist LT +12 more
europepmc +1 more source
177 Lu-FAP-2286 Combined Chemotherapy in a Case of Thymus Nonkeratinizing Squamous Carcinoma With Superior Vena Cava Syndrome. [PDF]
Deng J, Wang Y, Xu T, Chen Y.
europepmc +1 more source
Pathways and challenges in the clinical translational of radiopharmaceuticals for pediatric investigations. [PDF]
Stauff E +6 more
europepmc +1 more source

